Continuing its push into the protein analysis market, Qiagen will spend up to $17.6 million to acquire the assets of LumiCyte and the entire bioanalytical business of SuNyx.

Both companies make products for peptide and protein sample preparation that run on mass spectrometry instrumentation and will provide Qiagen with two more platforms for its rapidly emerging protein-analysis business.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.